Skip to content

Registry for Mayo Clinic Adult Congenital Heart Disease Control Population

Control Population for the Mayo Clinic Adult Congenital Heart Disease Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05773300
Enrollment
66
Registered
2023-03-17
Start date
2022-01-06
Completion date
2026-12-01
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI ≤ 30. * No current cardiac medications. * Systolic BP ≤ 140 mmHg. * Diastolic BP ≤ 90 mmHg. * Capacity to consent.

Exclusion criteria

* To be assessed via EMR screening. * Patient confirmation during screening visit. * Screening tests as applicable. * History of cardiovascular disease. eGFR \< 30. * Current orthopedic limitations.

Design outcomes

Primary

MeasureTime frameDescription
Peak Oxygen Uptake6 MonthsPeak Oxygen Uptake (L/min) : 1.7 ± 0.1
Peak Right Ventricular - Pulmonary Coupling6 MonthsPeak Right Ventricular - Pulmonary Coupling: (\|%\|/mmHg): 0.786 ± 0.065

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAlexander Egbe, MBBS, MPH

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026